학술논문
Tumour growth rate improves tumour assessment and first-line systemic treatment decision-making for immunotherapy in patients with liver metastatic uveal melanoma.
Document Type
Journal Article
Author
Source
Subject
*Melanoma
*Liver
*Uvea cancer
*Retrospective studies
*Secondary primary cancer
*Immunotherapy
*
*
*
*
*
Language
ISSN
0007-0920
Abstract